Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.

导出 LinkOut

翻译打印收藏纠错

作者： Jufan,Zhu ^[1] ; Luo,Wang ^[2] ; Yuanjun,Yang ^[1] ; Mengfei,Han ^[1] ; Yiheng,Yang ^[1] ; Renqian,Feng ^[1] ; Yan,Hu ^[1]

作者单位： Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. ^[1] Medical College of Zhejiang University, Hangzhou, Zhejiang, China. ^[2]

关键词 DNA damage ErbB receptors Ovarian neoplasms

主题词人类(Humans);女(雌)性(Female);肿瘤复发, 局部(Neoplasm Recurrence, Local);细胞增殖(Cell Proliferation);卵巢肿瘤(Ovarian Neoplasms);DNA损伤(DNA Damage);细胞系, 肿瘤(Cell Line, Tumor);肺肿瘤(Lung Neoplasms)

DOI 10.1177/10815589231158043

PMID 36859802

发布时间 2023-06-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of investigative medicine

2023年71卷5期

511-525页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.

Journal of investigative medicine

相似文献

Journal of investigative medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway.

Journal of investigative medicine

相似文献

Journal of investigative medicine

相关期刊

检索历史清除